170 related articles for article (PubMed ID: 11688325)
21. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
[TBL] [Abstract][Full Text] [Related]
22. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia.
Grau S; Antonio JM; Ribes E; Salvadó M; Garcés JM; Garau J
Int J Antimicrob Agents; 2006 Sep; 28(3):249-52. PubMed ID: 16870401
[TBL] [Abstract][Full Text] [Related]
23. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.
Plouffe JF; Breiman RF; Fields BS; Herbert M; Inverso J; Knirsch C; Kolokathis A; Marrie TJ; Nicolle L; Schwartz DB
Clin Infect Dis; 2003 Dec; 37(11):1475-80. PubMed ID: 14614670
[TBL] [Abstract][Full Text] [Related]
24. Macrolide antibiotics, drug interactions and microsomal enzymes: implications for veterinary medicine.
Anadón A; Reeve-johnson L
Res Vet Sci; 1999 Jun; 66(3):197-203. PubMed ID: 10333459
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I).
Periti P; Mazzei T; Mini E; Novelli A
Clin Pharmacokinet; 1989 Apr; 16(4):193-214. PubMed ID: 2656049
[TBL] [Abstract][Full Text] [Related]
26. [Antibiotics treatment of whooping cough].
Pontoppidan PE; Høgh B
Ugeskr Laeger; 2006 Aug; 168(34):2802-5. PubMed ID: 16942700
[No Abstract] [Full Text] [Related]
27. Chemistry and mode of action of macrolides.
Mazzei T; Mini E; Novelli A; Periti P
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():1-9. PubMed ID: 7683018
[TBL] [Abstract][Full Text] [Related]
28. Adverse effects of macrolide antibacterials.
Periti P; Mazzei T; Mini E; Novelli A
Drug Saf; 1993 Nov; 9(5):346-64. PubMed ID: 8280403
[TBL] [Abstract][Full Text] [Related]
29. The debate on antibiotic therapy for patients hospitalized for pneumonia: where should we go from here?
Lee JS; Fine MJ
JAMA Intern Med; 2014 Dec; 174(12):1901-3. PubMed ID: 25285980
[No Abstract] [Full Text] [Related]
30. Empirical Therapy of Community-Acquired Pneumonia: Advancing Evidence or Just More Doubt?
Mandell LA; Waterer GW
JAMA; 2015 Jul; 314(4):396-7. PubMed ID: 26219057
[No Abstract] [Full Text] [Related]
31. Legionnaires' disease: a rare entity in Puerto Rico?
Príncipe Rodríguez K; Rodríguez Cintrón W
P R Health Sci J; 2001 Sep; 20(3):251-3. PubMed ID: 11776727
[TBL] [Abstract][Full Text] [Related]
32. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy.
Gacouin A; Le Tulzo Y; Lavoue S; Camus C; Hoff J; Bassen R; Arvieux C; Heurtin C; Thomas R
Intensive Care Med; 2002 Jun; 28(6):686-91. PubMed ID: 12107671
[TBL] [Abstract][Full Text] [Related]
33. Pathogenicity of the family Legionellaceae.
Palusińska-Szysz M; Cendrowska-Pinkosz M
Arch Immunol Ther Exp (Warsz); 2009; 57(4):279-90. PubMed ID: 19578813
[TBL] [Abstract][Full Text] [Related]
34. Current clinical management of Legionnaires' disease.
Garcia-Vidal C; Carratalà J
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):995-1004. PubMed ID: 17181416
[TBL] [Abstract][Full Text] [Related]
35. Comparison of macrolide antibiotics.
Williams JD; Sefton AM
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():11-26. PubMed ID: 8478301
[TBL] [Abstract][Full Text] [Related]
36. [Therapy of pneumonia].
Stille W
ZFA (Stuttgart); 1980 Apr; 56(10):677-80. PubMed ID: 6998163
[No Abstract] [Full Text] [Related]
37. Fluoroquinolones vs macrolides in the treatment of Legionnaires disease.
Sabrià M; Pedro-Botet ML; Gómez J; Roig J; Vilaseca B; Sopena N; Baños V;
Chest; 2005 Sep; 128(3):1401-5. PubMed ID: 16162735
[TBL] [Abstract][Full Text] [Related]
38. [Legionnaires' disease: clinical aspects of complications, treatment and prognosis].
Temezhnikova ND; Sinopal'nikov AI
Voen Med Zh; 2008 Feb; 329(2):54-8. PubMed ID: 18416114
[No Abstract] [Full Text] [Related]
39. Pharmacokinetic drug interactions of macrolides.
Periti P; Mazzei T; Mini E; Novelli A
Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
[TBL] [Abstract][Full Text] [Related]
40. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
Bartlett JG
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
